In this video, we dive deep into the issues surrounding electoral bonds and their connection to pharmaceutical companies in India. We'll explore how despite warnings from the WHO about the ineffectiveness of Remdesivir, its production being ramped up in India, leading to severe health crises due to substandard batches from pharma companies. These companies are revealed to have made significant donations to political parties through electoral bonds. We will also discuss various instances where faulty drugs led to tragic outcomes. the subsequent lack of accountability, including insufficient action against the companies. Join us as we unpack these complex connections and the serious implications on public health, driven by political and corporate interests, highlighted by a myriad of reports and investigations into this pressing issue.
